1stOncology™: Cancer Intelligence Service – Page 9851 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Replimune to Present at the William Blair Biotech Focus Conference 2021

On July 7, 2021 Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, reported that Robert Coffin, Ph.D., President and Chief Research & Development Officer of Replimune, will participate in a panel titled "Novel Mechanisms and Strategies for Addressing PD-(L)1 Refractory/Resistant Tumors" at the William Blair Biotech Focus Conference 2021 taking place virtually on Wednesday, July 14, 2021 at 4:20 PM ET (Press release, Replimune, JUL 7, 2021, View Source [SID1234584660]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A simultaneous webcast will be available in the Investors section of Replimune’s website at www.replimune.com. A replay will be available for approximately 90 days following the conference.

Regeneron to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2021

On July 7, 2021 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported that it will report its second quarter 2021 financial and operating results on Thursday, August 5, 2021, before the U.S. financial markets open (Press release, Regeneron, JUL 7, 2021, View Source [SID1234584659]). The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.

Conference Call Information
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 9098036. A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at View Source A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.

Protara Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference

On July 7, 2021 Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, reported that management will present at the Ladenburg Thalmann Healthcare Conference being held in a virtual setting on Wednesday, July 14, 2021 at 10:00am ET (Press release, Protara Therapeutics, JUL 7, 2021, View Source [SID1234584658]).

A webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: View Source The webcast will be archived on the Company’s website for 90 days following the presentation.

Phio Pharmaceuticals Scheduled to Participate in a Fireside Chat with H.C. Wainwright on July 12th

On July 7, 2021 Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, reported that it will participate in a Fireside Chat with H.C. Wainwright at 11 a.m. Eastern Time on Monday, July 12, 2021 (Press release, Phio Pharmaceuticals, JUL 7, 2021, View Source [SID1234584657]).

Interested parties are asked to register ahead of time in order to listen to the live event at (click here) or through the "Investors – Events and Presentations" section of the Company’s website. The webcast will be archived and available on the Company’s website for 90 days.

Kinnate Biopharma Inc. to Participate in the William Blair Biotech Focus Conference 2021

On July 7, 2021 Kinnate Biopharma Inc. (Nasdaq: KNTE) ("Kinnate"), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, reported that its Chief Executive Officer Nima Farzan will participate in the William Blair Biotech Focus Conference 2021, being held virtually from July 14-15, 2021 (Press release, Kinnate Biopharma, JUL 7, 2021, View Source [SID1234584656]).

Event: William Blair Biotech Focus Conference 2021
Panel: "Next Generation Small Molecules in Oncology"
Location: Virtual
Date: Thursday, July 15, 2021
Time: 9:00 AM ET/ 6:00 AM PT

Members of the Kinnate management team will also host investor meetings during the conference.

A live webcast of the William Blair panel discussion will be available in the Investors and Media section of the Kinnate website at www.kinnate.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.